Search research articles
Contact Us
Filters
Showing results (321-330 of 324) with videos related to
Page
of 33
Sort By:
You have reached the last page of results.
This site can display upto 324 results.
Frontiers in Microbiology
|
June 18, 2020
A Novel miRNA-hlo-miR-2-Serves as a Regulatory Factor That Controls Molting Events by Targeting CPR1 in <i>Haemaphysalis longicornis</i> Nymphs
Wen-Ge Liu, Jin Luo, Qiao-Yun Ren, et al.
The AAPS Journal
|
December 2, 2021
Anti-drug Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Kelli Phillips, et al.
The AAPS Journal
|
July 8, 2023
Neutralizing Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
Bioanalysis
|
December 11, 2019
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)
Steven Piccoli, Devangi Mehta, Alessandra Vitaliti, et al.
Page
of 33
Search research articles
Search
Showing results (321-330 of 324) with videos related to
Sort By:
Page
of 33
You have reached the last page of results.
This site can display upto 324 results.
Frontiers in Microbiology
|
June 18, 2020
A Novel miRNA-hlo-miR-2-Serves as a Regulatory Factor That Controls Molting Events by Targeting CPR1 in <i>Haemaphysalis longicornis</i> Nymphs
Wen-Ge Liu, Jin Luo, Qiao-Yun Ren, et al.
The AAPS Journal
|
December 2, 2021
Anti-drug Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Kelli Phillips, et al.
The AAPS Journal
|
July 8, 2023
Neutralizing Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
Bioanalysis
|
December 11, 2019
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)
Steven Piccoli, Devangi Mehta, Alessandra Vitaliti, et al.
Page
of 33